Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study
Authors
Keywords
Pancreatic cancer, Cancer detection and diagnosis, Pancreatitis, Cancer risk factors, Gastrin, Type 2 diabetes, Alcohol consumption, Proton pumps
Journal
PLoS One
Volume 13, Issue 9, Pages e0203918
Publisher
Public Library of Science (PLoS)
Online
2018-09-13
DOI
10.1371/journal.pone.0203918
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
- (2017) Daniel E. Freedberg et al. GASTROENTEROLOGY
- Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis
- (2016) An Tran-Duy et al. Clinical Gastroenterology and Hepatology
- Prediagnosis Body Mass Index and Risk of Secondary Primary Cancer in Male Cancer Survivors: A Large Cohort Study
- (2016) Sang Min Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- Systematic review and meta-analysis: Small intestinal bacterial overgrowth in chronic pancreatitis
- (2016) Gabriele Capurso et al. United European Gastroenterology Journal
- Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis
- (2015) H. A. Risch et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis
- (2015) Annaka Schulte et al. CANCER CAUSES & CONTROL
- Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium
- (2014) C. Bosetti et al. ANNALS OF ONCOLOGY
- Gastrin
- (2014) Gemma Maddalo et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Risk factors for pancreatic cancer: a summary review of meta-analytical studies
- (2014) P. Maisonneuve et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth
- (2013) C. Jacobs et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Reported Side Effects and Complications of Long-term Proton Pump Inhibitor Use: Dissecting the Evidence
- (2012) David A. Johnson et al. Clinical Gastroenterology and Hepatology
- Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case–control study
- (2011) M C Bradley et al. BRITISH JOURNAL OF CANCER
- Anthropometric Measures, Body Mass Index, and Pancreatic Cancer
- (2010) Alan A. Arslan ARCHIVES OF INTERNAL MEDICINE
- Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection
- (2010) Sara Raimondi et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
- (2010) Lucio Lombardo et al. Clinical Gastroenterology and Hepatology
- Safety of Proton Pump Inhibitor Exposure
- (2010) Yu–Xiao Yang et al. GASTROENTEROLOGY
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Proton pump inhibitors: an update of their clinical use and pharmacokinetics
- (2008) Shaojun Shi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Tobacco and the risk of pancreatic cancer: a review and meta-analysis
- (2008) Simona Iodice et al. LANGENBECKS ARCHIVES OF SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More